258 related articles for article (PubMed ID: 2019772)
1. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
[TBL] [Abstract][Full Text] [Related]
3. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
4. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
5. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Kern WV; Cometta A; De Bock R; Langenaeken J; Paesmans M; Gaya H
N Engl J Med; 1999 Jul; 341(5):312-8. PubMed ID: 10423465
[TBL] [Abstract][Full Text] [Related]
6. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Bosseray A; Nicolini F; Brion JP; Michallet M; Hollard D; Stahl JP; Micoud M
Pathol Biol (Paris); 1992 Oct; 40(8):797-804. PubMed ID: 1484739
[TBL] [Abstract][Full Text] [Related]
8. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
[TBL] [Abstract][Full Text] [Related]
9. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
Gasparini G; Benedetti M; Fassio T; Canobbio L; Figoli F; Galligioni E; Talamini R; Toffoli G; Tumolo S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):113-20. PubMed ID: 3549581
[TBL] [Abstract][Full Text] [Related]
10. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
[TBL] [Abstract][Full Text] [Related]
12. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
Cometta A; Calandra T; Gaya H; Zinner SH; de Bock R; Del Favero A; Bucaneve G; Crokaert F; Kern WV; Klastersky J; Langenaeken I; Micozzi A; Padmos A; Paesmans M; Viscoli C; Glauser MP
Antimicrob Agents Chemother; 1996 May; 40(5):1108-15. PubMed ID: 8723449
[TBL] [Abstract][Full Text] [Related]
14. Empiric antibiotic therapy for granulocytopenic cancer patients.
Schimpff SC
Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.
Viscoli C; Moroni C; Boni L; Bruzzi P; Comelli A; Dini G; Fabbri A; Secondo V; Terragna A
Rev Infect Dis; 1991; 13(3):397-404. PubMed ID: 1866542
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Cometta A; Zinner S; de Bock R; Calandra T; Gaya H; Klastersky J; Langenaeken J; Paesmans M; Viscoli C; Glauser MP
Antimicrob Agents Chemother; 1995 Feb; 39(2):445-52. PubMed ID: 7726513
[TBL] [Abstract][Full Text] [Related]
17. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
Wade JC; Johnson DE; Bustamante CI
Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
[TBL] [Abstract][Full Text] [Related]
19. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
20. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
